A Phase II study of Ibrutinib, Rituximanb and mini-CHOP therapy in very elderly patients with newly diagnosed DLBCL
A Phase II study of Ibrutinib, Rituximanb and mini-CHOP therapy in very elderly patients with newly diagnosed DLBCL
Press Ctrl +⌘ + to increase font size.
Press Ctrl -⌘ - to decrease font size.
Press Ctrl 0⌘ 0 to reset font size.